Treace Medical Concepts (TMCI) News Today

Deepti Jain Buys 25,000 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) Stock
Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) Director Deepti Jain bought 25,000 shares of the business's stock in a transaction dated Friday, May 10th. The stock was acquired at an average price of $4.50 per share, for a total transaction of $112,500.00. Following the purchase, the director now directly owns 31,235 shares in the company, valued at $140,557.50. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.
Treace Medical Concepts (NASDAQ:TMCI) PT Lowered to $16.00
TimesSquare Capital Management LLC Raises Stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI)
TimesSquare Capital Management LLC boosted its position in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 22.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,749,120 shares of the co
UBS Group Lowers Treace Medical Concepts (NASDAQ:TMCI) Price Target to $16.00
UBS Group reduced their price target on Treace Medical Concepts from $17.00 to $16.00 and set a "buy" rating for the company in a report on Wednesday.
Treace Medical Concepts (NASDAQ:TMCI) Releases Earnings Results, Meets Estimates
Treace Medical Concepts (NASDAQ:TMCI - Get Free Report) released its earnings results on Tuesday. The company reported ($0.30) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.30). Treace Medical Concepts had a negative net margin of 26.47% and a negative return on equity of 33.96%. The firm had revenue of $51.11 million during the quarter, compared to analyst estimates of $49.07 million. During the same quarter last year, the business earned ($0.23) EPS. The business's revenue was up 21.1% on a year-over-year basis.
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the six analysts that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and five have issued a buy
Treace Announces First Annual National Bunion Day
7 Stable Stocks for 50% Returns by Early 2025
Treace Medical Concepts (NASDAQ:TMCI) Shares Down 5.2%
Treace Medical Concepts (NASDAQ:TMCI) Stock Price Down 5.2%
Vanguard Group Inc. Has $54.93 Million Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI)
Vanguard Group Inc. boosted its position in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 3.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,189,582 shares of the company's stock after
Treace Medical Concepts (NASDAQ:TMCI) Shares Down 4%
Treace Medical Concepts (NASDAQ:TMCI) Trading Down 4%
Treace Medical Concepts (NASDAQ:TMCI) Trading Up 7.6%
Treace Medical Concepts (NASDAQ:TMCI) Trading 7.6% Higher
Walleye Capital LLC Grows Stock Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI)
Walleye Capital LLC raised its holdings in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 171.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 139,839 shares of the company's stock aft
Qube Research & Technologies Ltd Buys 95,194 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI)
Qube Research & Technologies Ltd raised its stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 146.2% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 160,284 shares of th
TimesSquare Capital Management LLC Has $18.79 Million Stock Position in Treace Medical Concepts, Inc. (NASDAQ:TMCI)
TimesSquare Capital Management LLC grew its stake in shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI - Free Report) by 68.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,433,429 shares of the company's stock
Treace Medical Concepts Inc
Get Treace Medical Concepts News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter.

America’s worst nightmare? (Ad)

What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late.

Click here to watch this bombshell exposé now.

TMCI Media Mentions By Week

TMCI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TMCI
News Sentiment

0.19

0.56

Average
Medical
News Sentiment

TMCI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TMCI Articles
This Week

31

2

TMCI Articles
Average Week

Get Treace Medical Concepts News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMCI and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:TMCI) was last updated on 5/15/2024 by MarketBeat.com Staff

From Our Partners